Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

The state of our understanding of the pathophysiology and optimal treatment of depression: glass half full or half empty?

CB Nemeroff - American Journal of Psychiatry, 2020 - Am Psychiatric Assoc
Major depressive disorder is a remarkably common and often severe psychiatric disorder
associated with high levels of morbidity and mortality. Patients with major depression are …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines

A Cleare, CM Pariante, AH Young… - Journal of …, 2015 - journals.sagepub.com
A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …

Pharmacokinetics of selective serotonin reuptake inhibitors

C Hiemke, S Härtter - Pharmacology & therapeutics, 2000 - Elsevier
The five selective serotonin reuptake inhibitors (SSRIs), fluoxetine, fluvoxamine, paroxetine,
sertraline, and citalopram, have similar antidepressant efficacy and a similar side effect …

Psychomotor retardation in depression: biological underpinnings, measurement, and treatment

JS Buyukdura, SM McClintock, PE Croarkin - Progress in Neuro …, 2011 - Elsevier
Psychomotor retardation is a long established component of depression that can have
significant clinical and therapeutic implications for treatment. Due to its negative impact on …

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

IM Anderson - Journal of affective disorders, 2000 - Elsevier
Background: A meta-analysis of the efficacy and tolerability of selective serotonin reuptake
inhibitors (SSRIs) against tricyclic antidepressants (TCAs) in depressed patients was carried …

The internal and external validity of the Major Depression Inventory in measuring severity of depressive states

LR Olsen, DV Jensen, V Noerholm, K Martiny… - Psychological …, 2003 - cambridge.org
Background. We have developed the Major Depression Inventory (MDI), consisting of 10
items, covering the DSM-IV as well as the ICD-10 symptoms of depressive illness. We aimed …

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

HA Sackeim, RF Haskett, BH Mulsant, ME Thase… - Jama, 2001 - jamanetwork.com
ContextElectroconvulsive therapy (ECT) is highly effective for treatment of major depression,
but naturalistic studies show a high rate of relapse after discontinuation of ECT. ObjectiveTo …

The therapeutic role of 5-HT1A and 5-HT2A receptors in depression

P Celada, MV Puig, M Amargós-Bosch, A Adell… - Journal of psychiatry and …, 2004 - jpn.ca
The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed
antidepressant drugs, because they are well tolerated and have no severe side effects. They …

Weight gain and antidepressants

M Fava - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …